Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

INDUSTRY 2OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 13Gynecologic 8Sarcoma 4Head & Neck 4Breast 4Genitourinary 3Dermatologic 3Thoracic 1Other 1NET 1Endocrine 1CNS 1

Conditions

Lung Neoplasms 3647Carcinoma, Non-Small-Cell Lung 3587Small Cell Lung Carcinoma 578Breast Neoplasms 420Neoplasms 299Adenocarcinoma of Lung 249Colorectal Neoplasms 222Melanoma 201Mesothelioma, Malignant 183Pancreatic Neoplasms 179Brain Neoplasms 179Prostatic Neoplasms 178Head and Neck Neoplasms 173Neoplasm Metastasis 167Ovarian Neoplasms 153Esophageal Neoplasms 152Mesothelioma 145Colonic Neoplasms 140Stomach Neoplasms 139NSCLC 115Pleural Effusion, Malignant 114Carcinoma, Renal Cell 109Urinary Bladder Neoplasms 106Disease 96Sarcoma 85Uterine Cervical Neoplasms 82Thymoma 79Liver Neoplasms 77Motor Activity 75Squamous Cell Carcinoma of Head and Neck 72

Interventions

Immune Checkpoint Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Hyperthermia × Thoracic × Clear all
NCT05520853 2022-08-30

SBRT Combined With PD-1 Inhibitor and Thoracic Hyperthermia for Advanced NSCLC

First People's Hospital of Hangzhou

Phase 2 Unknown
63 enrolled
Thoracic

Hyperthermia, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡